Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
On July 8, 2024, HilleVax was the subject of a Fierce Biotech article. According to the article, “HilleVax’s stock took a nosedive after the vaccine biotech’s sole clinical-stage candidate failed a phase 2b trial in norovirus-related acute gastroenteritis (AGE).” The article continues, “The virus-like particle-based vaccine, dubbed HIL-214, missed all primary and secondary endpoints of the NEST-IN1 study of more than 2,800 infants aged about five months of age in the U.S. and Latin America.”
Ticker Symbol | Company Name | Join Deadline | Join |
---|---|---|---|
SMCI | Super Micro Computer, Inc. | October 29, 2024 | Join |
ZI | ZoomInfo Technologies Inc. | November 04, 2024 | Join |
WBTN | WEBTOON Entertainment Inc. | November 04, 2024 | Join |
GTLB | GitLab Inc. | November 04, 2024 | Join |
GTLB | GitLab Inc. | November 04, 2024 | Join |
AGEN | Agenus Inc. | November 05, 2024 | Join |
NFE | New Fortress Energy Inc. | November 18, 2024 | Join |
MGX | Metagenomi, Inc. | November 25, 2024 | Join |
BMBL | Bumble Inc. | November 25, 2024 | Join |
UPS | United Parcel Service, Inc. | December 09, 2024 | Join |
EW | Edwards Lifesciences Corporation | December 13, 2024 | Join |
TD | The Toronto-Dominion Bank | December 23, 2024 | Join |